Key facts
- This page summarizes Andrew Lawrence Taylor's Form 4 filing for Orchestra BioMed Holdings, Inc. (OBIO).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 09 Nov 2026, 16:30.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Purchase
Additional SEC filing notes
Footnote F1
These shares were purchased in an underwritten public offering of the Issuer at the public offering price of $5.00 per share.